Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vor Biopharma Inc.

0.6856
+0.02463.72%
Volume:69.08K
Turnover:47.27K
Market Cap:85.60M
PE:-0.40
High:0.6929
Open:0.6899
Low:0.6700
Close:0.6610
Loading ...
Mar 14, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Nov 10, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 09, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 17, 2021

Major Issues Report

8-K - Current report
May 06, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 25, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 10, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 19, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Feb 19, 2021

Beneficial Ownership Change

SC 13D - General statement of acquisition of beneficial ownership
Feb 09, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 09, 2021

Major Issues Report

8-K - Current report
Feb 03, 2021

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Feb 03, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Feb 02, 2021

Correspondence

CORRESP [Cover] - Correspondence
Feb 02, 2021

Correspondence

CORRESP [Cover] - Correspondence
Feb 01, 2021

Correspondence

CORRESP [Cover] - Correspondence
Feb 01, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Jan 21, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jan 15, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jan 15, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933